A Reason to Give Thanks this Holiday Season
December 7, 2017
Decades of funding and research may finally be paying off for critically ill lymphoma patients and young leukemia patients now that gene therapy has been approved in the United States. The Leukemia and Lymphoma Society (LLS) has played an integral role in these life saving accomplishments.
What’s referred to as CAR T-cell immunotherapy was recently approved by the U.S. Food and Drug Administration for two pharmaceutical companies. The personalized cell therapy supercharges the immune system to find and kill cancer cells. It’s being heralded as a new era in cancer treatment.
Kymriah is a gene therapy developed by Swiss pharmaceutical giant Novartis. It’s available to patients up to 25-years-old with the most common type of acute lymphoblastic leukemia (ALL) who are not responding to treatment or have suffered a relapse.
LLS backed the medical experts who pioneered Kymriah for decades. Through multiple grants, LLS awarded more than $20 million to the research team at the University of Pennsylvania and Children’s Hospital of Philadelphia.
LLS President and CEO Louis J. DeGennaro, Ph.D. has expressed pride in the organization’s foresight. “We first began to see remarkable outcomes for some of these patients in 2010 leading us to increase our funding of CAR T therapy by supporting more than 10 major laboratories developing this method.”
Yescarta is another CAR T therapy approved this year and treats several types of non-Hodgkin lymphoma (NHL), among patients who have not responded to previous treatments. It was developed by Kite, a Gilead Company and LLS supported the clinical trial leading to Yescarta’s approval. In that clinical trial, 51 percent of patients had a complete response with no detectable cancer remaining.
Our firm’s association with the Leukemia and Lymphoma Society Palm Beach Area Chapter has allowed us to see first-hand the commitment of healthcare professionals battling blood cancers and community volunteers assisting families in turmoil. The organization offers support groups for patients and their loved ones and education programs that explore treatment options and coping skills.
Of course, the overriding mission of LLS is to raise money for research with the goal of advancing treatments and saving lives. In recognizing the promise of CAR T therapy drugs and investing millions in research and development, LLS has carried through to its goal. We are thankful for their perseverance.
Sources: LLS 1, LLS 2, LLS 3, New York Times, FDA, Cancer.gov, Yahoo News, New York Times 2, New York Times 3, FDA
Disclaimer: The information on this website and blog is for general informational purposes only and is not professional advice. We make no guarantees of accuracy or completeness. We disclaim all liability for errors, omissions, or reliance on this content. Always consult a qualified professional for specific guidance.
Recent Posts
By: Stephanie Serafin The latest results from Florida’s General Bar Exam have been released and once again law students from my alma mater delivered a stellar performance. The University of Miami School of Law was among only three schools to have more than 80% of their students pass the July exam. According to the Florida Supreme Court website, 84.2% of law students from UM were successful on the pass/fail test. My colleague Rebecca Mercier Vargas is a graduate of Florida State University College of Law and candidates from her alma mater also performed well, with 83.9% passing the exam. Florida International University is the top performer, with 87.8% of its students making the grade. In all, 1,553 candidates from 12 Florida law schools were approved by the state Supreme Court for admission to the Florida Bar. Induction ceremonies are scheduled for next month. Looking back on the strenuous academic challenges and stressful plight of law students determined to cross into the law profession, I want to express congratulations to all successful candidates and welcome them to the world of law.
Read our blogs about gap pump credit card skimming and know more about this financial fraud. Call us at 561-659-5455 to know more.
Read our blog about local charity assists families affected by drug additions. Call us at 561-659-5455 to know more.
Read our blog about the importance of jury duty & know what role jurors play at the core of our democracy. Call us at 561-659-5455 to know more.
